Harnessing the Role of ESR1 in Breast Cancer: Correlation with microRNA, lncRNA, and Methylation
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26073101 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Shengping Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pennington Biomedical Research Center, 6400 Perkins Rd., Baton Rouge, LA 70808, USA. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Estrogen Receptor alpha, RNA, Long Noncoding. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health.
Abstract (Originalsprache)
Breast cancer (BC) is a multifactorial condition and it primarily expresses the estrogen receptor α (ERα) that is encoded by the gene estrogen receptor 1 (ESR1), which modulates estrogen signaling. ESR1, by facilitating estrogen overproduction, plays an indispensable role in the progression and survival of the majority of BCs. To obtain molecular insights into these phenomena, we analyzed The Cancer Genome Atlas (TCGA) breast invasive carcinoma (BRCA) RNA-Seq datasets for the expression of ESR1 and its correlation to microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), along with its methylation patterns. Regulation of ESR1 was also assessed with a total of 43 cancerous and non-cancerous breast cell lines. Analyses of both TCGA BRCA and breast cell line RNA-Seq data revealed that specific lncRNAs, i.e., MEG3, BIK, MLL, and FAS are negatively correlated with the ESR1, in which PARP1 demonstrates a positive association. Additionally, both miR-30a and miR-145 showed negative correlations with the ESR1 expression. Of the 54 ESR1 methylation loci analyzed, the majority of them exhibited a negative correlation with the ESR1 expression, highlighting a potentially modifiable regulatory mechanism. These findings underscore the complex regulatory events influencing ESR1 expression and its interaction with diverse signaling pathways, demonstrating novel insights into breast pathogenesis and its potential therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pennington Biomedical Research Center, 6400 Perkins Rd., Baton Rouge, LA 70808, USA.
- Baylor College of Medicine, Ben Taub Research Center, 1 Baylor Plaza, Houston, TX 77030, USA.
- Department of Internal Medicine, School of Medicine, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430, USA.
ORCID-Profile: Shengping Yang, Pulak R Manna
Förderung
- NIGMS NIH HHS
- NIH HHS
- U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health
- Louisiana Clinical and Translational Science Center
- Department of Internal Medicine and The CH Foundation
- The CH Foundation
Zitieren
APA
Yang, S., Manna, C., & Manna, P. R. (2025). Harnessing the Role of ESR1 in Breast Cancer: Correlation with microRNA, lncRNA, and Methylation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073101
Vancouver
Yang S, Manna C, Manna PR. Harnessing the Role of ESR1 in Breast Cancer: Correlation with microRNA, lncRNA, and Methylation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073101
BibTeX
@article{Yang2025,
author = {Yang, Shengping and Manna, Chayan and Manna, Pulak R},
title = {Harnessing the Role of ESR1 in Breast Cancer: Correlation with microRNA, lncRNA, and Methylation},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26073101}
}
EUVIMED